Serveur d'explorations sur les aspects psychologiques du Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.

Identifieur interne : 000529 ( Main/Corpus ); précédent : 000528; suivant : 000530

Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.

Auteurs : Fadi Taza ; Mary Zulty ; Arjun Kanwal ; Daniel Grove

Source :

RBID : pubmed:32540884

English descriptors

Abstract

COVID-19 became a global pandemic in early 2020. While well known for its pulmonary manifestations, the virus also has a number of cardiac manifestations as well. Takotsubo syndrome has scarcely been reported in patients with COVID-19, but it is possible that the cytokine storm associated with the infection can trigger Takotsubo syndrome in patients with underlying risk factors for Takotsubo (emotional distress, physical distress, history of psychiatric disorders).

DOI: 10.1136/bcr-2020-236561
PubMed: 32540884
PubMed Central: PMC7298682

Links to Exploration step

pubmed:32540884

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.</title>
<author>
<name sortKey="Taza, Fadi" sort="Taza, Fadi" uniqKey="Taza F" first="Fadi" last="Taza">Fadi Taza</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zulty, Mary" sort="Zulty, Mary" uniqKey="Zulty M" first="Mary" last="Zulty">Mary Zulty</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kanwal, Arjun" sort="Kanwal, Arjun" uniqKey="Kanwal A" first="Arjun" last="Kanwal">Arjun Kanwal</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA arjun.kanwal@medstar.net.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Grove, Daniel" sort="Grove, Daniel" uniqKey="Grove D" first="Daniel" last="Grove">Daniel Grove</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32540884</idno>
<idno type="pmid">32540884</idno>
<idno type="doi">10.1136/bcr-2020-236561</idno>
<idno type="pmc">PMC7298682</idno>
<idno type="wicri:Area/Main/Corpus">000529</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000529</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.</title>
<author>
<name sortKey="Taza, Fadi" sort="Taza, Fadi" uniqKey="Taza F" first="Fadi" last="Taza">Fadi Taza</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zulty, Mary" sort="Zulty, Mary" uniqKey="Zulty M" first="Mary" last="Zulty">Mary Zulty</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kanwal, Arjun" sort="Kanwal, Arjun" uniqKey="Kanwal A" first="Arjun" last="Kanwal">Arjun Kanwal</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA arjun.kanwal@medstar.net.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Grove, Daniel" sort="Grove, Daniel" uniqKey="Grove D" first="Daniel" last="Grove">Daniel Grove</name>
<affiliation>
<nlm:affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMJ case reports</title>
<idno type="eISSN">1757-790X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized (administration & dosage)</term>
<term>Anticoagulants (administration & dosage)</term>
<term>Betacoronavirus (isolation & purification)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>Coronary Angiography (methods)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Electrocardiography (methods)</term>
<term>Heparin (administration & dosage)</term>
<term>Humans</term>
<term>Immunologic Factors</term>
<term>Male</term>
<term>Methylprednisolone (administration & dosage)</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Respiration, Artificial (methods)</term>
<term>Respiratory Insufficiency (etiology)</term>
<term>Respiratory Insufficiency (therapy)</term>
<term>Schizophrenia (complications)</term>
<term>Takotsubo Cardiomyopathy (blood)</term>
<term>Takotsubo Cardiomyopathy (diagnosis)</term>
<term>Takotsubo Cardiomyopathy (etiology)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized</term>
<term>Anticoagulants</term>
<term>Heparin</term>
<term>Methylprednisolone</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Takotsubo Cardiomyopathy</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Takotsubo Cardiomyopathy</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Respiratory Insufficiency</term>
<term>Takotsubo Cardiomyopathy</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Coronary Angiography</term>
<term>Electrocardiography</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Immunologic Factors</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">COVID-19 became a global pandemic in early 2020. While well known for its pulmonary manifestations, the virus also has a number of cardiac manifestations as well. Takotsubo syndrome has scarcely been reported in patients with COVID-19, but it is possible that the cytokine storm associated with the infection can trigger Takotsubo syndrome in patients with underlying risk factors for Takotsubo (emotional distress, physical distress, history of psychiatric disorders).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32540884</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>06</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1757-790X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2020</Year>
<Month>Jun</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>BMJ case reports</Title>
<ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e236561</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2020-236561</ELocationID>
<Abstract>
<AbstractText>COVID-19 became a global pandemic in early 2020. While well known for its pulmonary manifestations, the virus also has a number of cardiac manifestations as well. Takotsubo syndrome has scarcely been reported in patients with COVID-19, but it is possible that the cytokine storm associated with the infection can trigger Takotsubo syndrome in patients with underlying risk factors for Takotsubo (emotional distress, physical distress, history of psychiatric disorders).</AbstractText>
<CopyrightInformation>© BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Taza</LastName>
<ForeName>Fadi</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zulty</LastName>
<ForeName>Mary</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kanwal</LastName>
<ForeName>Arjun</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-6370-289X</Identifier>
<AffiliationInfo>
<Affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA arjun.kanwal@medstar.net.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grove</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>06</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMJ Case Rep</MedlineTA>
<NlmUniqueID>101526291</NlmUniqueID>
<ISSNLinking>1757-790X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9005-49-6</RegistryNumber>
<NameOfSubstance UI="D006493">Heparin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>I031V2H011</RegistryNumber>
<NameOfSubstance UI="C502936">tocilizumab</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054549" MajorTopicYN="Y">Takotsubo Cardiomyopathy</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">adult intensive care</Keyword>
<Keyword MajorTopicYN="N">cardiovascular medicine</Keyword>
<Keyword MajorTopicYN="N">heart failure</Keyword>
<Keyword MajorTopicYN="N">infectious diseases</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>6</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32540884</ArticleId>
<ArticleId IdType="pii">13/6/e236561</ArticleId>
<ArticleId IdType="doi">10.1136/bcr-2020-236561</ArticleId>
<ArticleId IdType="pmc">PMC7298682</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Eur Heart J. 2020 May 14;41(19):1860</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32285915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2015 Sep 3;373(10):929-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26332547</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2004 Dec 7;141(11):858-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15583228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Case Rep Intern Med. 2020 Apr 21;7(5):001665</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32399453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ J. 2014;78(9):2129-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25131525</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 2006 Jul;27(13):1523-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16720686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2018 Dec;564(7735):273-277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30542164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32192578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Angiology. 2017 Apr;68(4):288-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27303068</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidPsychoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000529 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000529 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidPsychoV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32540884
   |texte=   Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32540884" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidPsychoV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Fri Jul 31 19:14:22 2020. Site generation: Thu Mar 25 19:13:26 2021